Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sibte Burney"'
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 3, Pp 601-602 (2019)
Candida auris is an emerging fungus that can cause invasive infections. It is associated with high mortality rates and resistance to multiple classes of antifungal drugs and is difficult to identify with standard laboratory methods. We describe the m
Externí odkaz:
https://doaj.org/article/fdc19ad001584d27a17b5138b20af1e0
Publikováno v:
Infectious Diseases in Clinical Practice. 25:82-87
BackgroundThe current health care–associated pneumonia (HCAP) model may be too broad, leading to inappropriate use of broad-spectrum antibiotics. As a result, therapeutic algorithms, such as what Maruyama et al validated, have been developed for a
Publikováno v:
Emerging Infectious Diseases
Candida auris is an emerging fungus that can cause invasive infections. It is associated with high mortality rates and resistance to multiple classes of antifungal drugs and is difficult to identify with standard laboratory methods. We describe the m
Publikováno v:
Open Forum Infectious Diseases. 2
Autor:
Elaine Atwood, John Quale, Barry Kreishwirth, Barbara M. Willey, Virginia Ditore, David Landman, Sibte Burney, Keval Patel, Mohammed Zaman, Elise Oydna, Guillermo Saurina, Winnie Huang
Publikováno v:
American Journal of Infection Control. 24:372-379
Background: Vancomycin-resistant enterococci (VRE) were first detected in our institution in 1991. An outbreak was recognized in late 1992 when there was a sudden rise in the number of patients per month with VRE. Little information exists concerning
Autor:
Simona Bratu, Jyoti Gupta, David Landman, Sibte Burney, John Quale, Steven E. Brooks, Sandeep Kochar
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 44(7)
A carbapenem-resistant isolate of Escherichia coli was identified that possessed a 23-kb plasmid encoding Klebsiella pneumoniae carbapenemase type 2 (KPC-2). A subsequent surveillance study involving hospitals in Brooklyn, New York, revealed that, am
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:1668-1670
Enterococci resistant to ampicillin, vancomycin, and/or aminoglycosides are a growing clinical problem. We studied the in vitro activity of the new fluoroquinolone clinafloxacin (PD 127,391) against 15 clinical isolates of multidrug-resistant Enteroc
Publikováno v:
The Journal of antimicrobial chemotherapy. 37(2)
Antibiotic resistant strains of enterococci are being isolated with increasing frequency. Effective treatment of infections caused by Enterococcus faecium resistant to ampicillin, vancomycin and aminoglycosides has not been established. We studied th
Publikováno v:
The American journal of Chinese medicine. 24(2)
Fluconazole-resistant Candida species are an emerging problem. In this report, the in vitro activity of C. zeylanicum against fluconazole-resistant and -susceptible Candida isolates is described. The MICs of the bark of C. zeylanicum ranged from < 0.
Publikováno v:
The Journal of antimicrobial chemotherapy. 37(1)
Clinafloxacin, a new quinolone antibiotic with enhanced activity against Gram-positive bacteria, has demonstrated in-vitro activity against multidrug-resistant Enterococcus faecium, particularly when combined with penicillin. Rabbits with experimenta